Market Place
Sourcing Support
All News #Library
Rare Diseases
EMA Seeks Input On Drafting Myasthenia Gravis Trial Guide
19 Feb 2026 //
RAPS
Targeted Myasthenia Gravis Therapies Flood Sparse Market
15 Sep 2025 //
BIOSPACE
Argenx and Seles Collaborate for Myasthenia Gravis Awareness
12 Aug 2025 //
FIERCE PHARMA
argenx progresses ARGX-119 for Congenital Myasthenic Syndromes
30 Jun 2025 //
GLOBENEWSWIRE
Argenx gets EU approval for Vyvgart injection for CIDP
20 Jun 2025 //
GLOBENEWSWIRE
Argenx Announces Positive CHMP Opinion for Vygar Injection
28 Apr 2025 //
GLOBENEWSWIRE
Argenx Highlights Data at 2024 Multiple Immunology Programs
15 Oct 2024 //
GLOBENEWSWIRE
Argenx`s Vyvgart Competes Well With AstraZeneca In Myasthenia Gravis
25 Jul 2024 //
FIERCE PHARMA
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.